TI
PRAX icon

Trexquant Investment’s Praxis Precision Medicines PRAX Stock Holding History

Trexquant Investment’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,626
Closed -$2.13M – 2154
2026
Q1 		$2.13M Sell
6,626
-1,705
-20% -$527K 0.02% 971
2025
Q4 		$2.46M Sell
8,331
-574
-6% -$107K 0.02% 914
2025
Q3 		$472K Buy
+8,905
New +$432K ﹤0.01% 1329
2025
Q1 		– Sell
-9,115
Closed -$701K – 1808
2024
Q4 		$701K Sell
9,115
-6,317
-41% -$457K 0.01% 1200
2024
Q3 		$888K Sell
15,432
-7,375
-32% -$398K 0.01% 1086
2024
Q2 		$943K Buy
22,807
+18,464
+425% +$873K 0.01% 1016
2024
Q1 		$265K Buy
+4,343
New +$195K 0.01% 1318
2022
Q2 		– Sell
-1,870
Closed -$286K – 1791
2022
Q1 		$286K Buy
1,870
+804
+75% +$165K 0.01% 1031
2021
Q4 		$315K Buy
+1,066
New +$313K 0.02% 890

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Trexquant Investment's PRAX Position: Q2 2026 in Review

Trexquant Investment sold out of Praxis Precision Medicines (PRAX) in Q2 2026, closing a stake of 6,626 shares — an estimated $2.13M sold.

Trexquant Investment first reported a position in PRAX in Q4 2021 and held it in 9 quarters. The position peaked at $2.46M in Q4 2025. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Trexquant Investment reported no remaining Praxis Precision Medicines position as of Q2 2026 after selling out during the quarter.
  • Trexquant Investment sold 6,626 Praxis Precision Medicines shares in Q2 2026, an estimated $2.13M.
  • Trexquant Investment first reported a position in Praxis Precision Medicines in Q4 2021 and held it in 9 quarters.
  • Trexquant Investment's Praxis Precision Medicines position peaked at $2.46M in Q4 2025.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.